To further determine a key target governing GalNAc-T14-dependent metastatic potential, multiple lung cancer clinicogenomics databases for patient overall survival (GSE36471) (Fig. 3C) and cancer stage and recurrence (GSE31210 and GSE8894) (Fig. 3D) were examined. The gene discussed is GALNT14; the disease is lung carcinoma.